Advertisement

Clinical Laboratory Predictors of the Outcome of the Acute Period of Atherothrombotic Ischemic Stroke

  • S. I. Shkrobot
  • N. R. Sokhor
  • L. S. Milevska-Vovchuk
Article

Objectives. To clarify clinical and laboratory predictors of the acute period of atherothrombotic ischemic stroke (ATS). Materials and methods. Clinical symptomatology, the numbers of peripheral blood leukocytes in apoptosis and necrosis, and the state of the intracellular antioxidant system were assessed in 199 patients. Results and discussion. Among the clinical factors with negative influences on the course of the acute period of ATS, the most important were focus size, impairment to consciousness on day 1, initial SBP, and patient’s age (regression parameter R including clinical factors on day 1 was 0.496, p = 0.01, R on day 7 was 0.739, p < 0.0001; R on day 14 was 0.620, p < 0.0001). Mitochondrial dysfunction and mitochondrion-induced apoptosis were found to have direct influences on the course of ATS in the acute period. Direct relationships were found between the severity of ATS and the number of Mito+ cells on days 1 (r = 0.742, p = 0.009) and 7 (r = 0.717; p = 0.002) and between the severity of ATS and the content of ANV+ leukocytes on days 7 (r = 0.595; p = 0.015) and 14 (r = 0.670; p = 0.007), along with a negative correlation between total SOD and Mn-SOD activities of day 7 (r = 0.628; p = 0.010 and r = 0.675; p = 0.008, respectively), which is evidence for the prognostic value of these indicators.

Keywords

atherothrombotic stroke predictors of the course of the acute period of stroke mitochondrial dysfunction intracellular oxidative stress leukocyte apoptosis necrosis leukocytes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ch. P. Vorlou (ed.), Stroke. Practical Guidelines for Patient Management, Politekhnika, St. Petersburg (2001).Google Scholar
  2. 2.
    L. Caplan, Caplan’s Stroke: A Clinical Approach, Butterworth-Heinemann (2000), 3rd edition.Google Scholar
  3. 3.
    P. Rothwell, “Atherothrombosis and ischemic stroke,” BMJ, 334, No. 7590, 379–380 (2007), doi:  https://doi.org/10.1136/bmj.38964.489051.80.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    O. Bang, “Intracranial atherosclerosis: current understanding and perspectives,” Stroke, 16, No. 1, 27–35 (2014), doi:  https://doi.org/10.5853/jos.2014.16.1.27.CrossRefGoogle Scholar
  5. 5.
    T. Gao, W. Yu, and C. Liu, “Mechanisms of ischemic stroke in patients with intracranial atherosclerosis: A high-resolution magnetic resonance imaging study,” Exp. Ther. Med., 7, No. 5, 1415–1419 (2014), doi:  https://doi.org/10.3892/etm.2014.1600.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    S. Ballinger, C. Patterson, and C. Knight-Lozano, “Mitochondrial integrity and function in atherogenesis,” Circulation, 106, 544–549 (2002), doi:  https://doi.org/10.1161/01.cir.0000023921.93743.89.CrossRefPubMedGoogle Scholar
  7. 7.
    H. Huang, F. Guo, Y. Cao, W. Shi, and Q. Xia, “Neuroprotection by manganese superoxide dismutase (Mn-SOD) mimics: antioxidant effect and oxidative stress regulation in acute experimental stroke,” CNS Neurosci. Ther., 18, 811–818 (2012), doi:  https://doi.org/10.1111/j.1755-5949.2012.00380. CrossRefPubMedGoogle Scholar
  8. 8.
    M. Nemethova, V. Danielisova, M. Gottlieb, and J. Burda, “Post-conditioning exacerbates the MnSOD immune-reactivity after experimental cerebral global ischemia and reperfusion in the rat brain hippocampus,” Cell Biol. Int., 32, 128–135 (2008), doi:  https://doi.org/10.1016/j.cellbi.2007.08.023.CrossRefPubMedGoogle Scholar
  9. 9.
    K. Niizuma, H. Endo, and P. Chan, “Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival,” J. Neurochem., 109, Suppl. 1, 133–138 (2009), doi:  https://doi.org/10.1111/j.1471-4159.2009.05897.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    J. Jung, G. Kim, H. Chen, C. Maier, P. Narasimhan, Y. Song, K. Niisuma, M. Katsu, N. Okami, H. Yoshioka, H. Sakata, C. Goeders, and P. Chan, “Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection,” Mol. Neurobiol., 41, No. 2–3, 172–179 (2010), doi:  https://doi.org/10.1007/s12035-010-8102.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    M. Valko, D. Leibfritz, J. Moncol, M. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” Int. J. Biochem. Cell Biol., 39, 44–84 (2007), doi:  https://doi.org/10.1016/j.biocel.2006.07.001.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • S. I. Shkrobot
    • 1
  • N. R. Sokhor
    • 1
  • L. S. Milevska-Vovchuk
    • 1
  1. 1.Ternopol State Medical UniversityUkrainian Ministry of HealthTernopolUkraine

Personalised recommendations